Early transplantation benefits older, higher-risk MDS patients in study

12/13/2011 | MDSBeacon.com

Older patients with higher-risk myelodysplastic syndromes who received early stem cell transplantation and reduced-intensity chemotherapy survived longer than those who did not receive transplants, a study found. Researchers also said older patients with lower-risk MDS should not get early stem cell transplantation unless their quality of life is considerably diminished.

View Full Article in:

MDSBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY